Seattle Children's Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Seattle Children's Hospital sits in the top decile of US sponsors by registered trial count (#172 of 15,742 sponsors by registered trial count).
Seattle Children's Hospital: 168 sponsored US clinical trials, 29 recruiting.
Seattle Children's Hospital sponsors 168 registered US clinical trials on ClinicalTrials.gov, 29 of them currently recruiting, and 110 completed. 11 of these trials are in Phase 3-4 (later-stage) and 40 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Germ Cell Tumor, with 4 trials.
Top-decile sponsor footprint
Seattle Children's Hospital ranks in the top decile of sponsors by registered trial count (#172 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
110 of 117 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
168 total, page 4 of 4
Curcumin in Pediatric Inflammatory Bowel Disease
NCT00889161
Self-Management of Cancer-Related Fatigue by Adolescents
NCT00862186
Effect of Occupational Therapy on the Function and Mobility of Elbow Fractures
NCT00871793
Intraarticular Corticosteroid Therapy in Perthes Disease.
NCT01026909
Ultrasound-guided Rectus Sheath Block for Post-operative Pain Control Following Umbilical Hernia Repair
NCT00836134
Pilot Evaluation of a Walking School Bus Program
NCT00758615
Familial Overweight: Comparing Use of Strategies
NCT00746629
Internet-Based Program to Improve Asthma Management in Children
NCT00377663
Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
NCT00443430
Antimicrobial Resistance in Cystic Fibrosis (CF)
NCT00360503
Airflow Obstruction and Biomarkers of Airway Inflammation During and Following Acute Exacerbations of Childhood Asthma
NCT01227070
Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR
NCT00393042
Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age
NCT00242424
Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis
NCT00097773
Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)
NCT00153634
Child and Infant Learning Project
NCT00077831
Ketorolac in Postoperative Infants: Pharmacokinetics and Safety
NCT01260883
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors
NCT00003194
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 33 |
| Phase 2 | 7 |
| Phase 3 | 5 |
| Phase 4 | 6 |
Therapeutic Areas
What is open in the Seattle Children's Hospital pipeline
29 recruiting of 168 indexed (17% open); 110 completed (65%).
Phase mix: 11 late (III/IV) vs 40 early (I/II) (early-phase heavy).
Top condition: Germ Cell Tumor (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Seattle Children's Hospital: open-pipeline peers nationwide
Peers matched on 168 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Seattle Children's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 168 trials (± recruiting share)
- Astellas Pharma Global Development · 168 trials · 11% recruiting
- Bausch Health Americas · 168 trials · 4% recruiting
- Sumitomo Pharma America · 168 trials · 4% recruiting
- University of New Mexico · 168 trials · 1% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Johns Hopkins University · 17% recruiting · 1,448 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
- Baylor Research Institute · 17% recruiting · 180 trials
Related
What to do with this Seattle Children's Hospital page
168 registered trials is a research-attention snapshot, not an endorsement of Seattle Children's Hospital or any single study.
- 29 of Seattle Children's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Germ Cell Tumor is the condition Seattle Children's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Germ Cell Tumor trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Seattle Children's Hospital pipeline card: 168 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.